15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 8 firms covering Qiagen NV, 4 rate it Buy or better, 4 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $36.00 to $54.00, a moderate spread. The average target of $43.75 sits 3% above the current $42.39. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.65 next quarter toward $2.61 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS8 ratings
Moderate Buy
Strong Buy00%
Buy450%
Hold450%
Sell00%
Strong Sell00%
Based on 8 analysts giving stock ratings to Qiagen NV.
As of Sep, 4 of 8 firms rate QGEN a Buy (4 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
QGEN EPS & revenue forecast
EPS · NEXT QUARTER
$0.65
Range $0.64 – $0.67 · 8 analysts · +6% YoY
Next period, 8 analysts expect Qiagen NV to earn $0.65 a share (range $0.64 – $0.67), versus $0.62 a year earlier. Full-year consensus is $2.43, growing to $2.61 the year after.
REVENUE · NEXT QUARTER
$573.7M
Range $569.0M – $584.0M · 8 analysts · +6% YoY
Revenue is expected to reach $573.7M (range $569.0M – $584.0M), +6.2% year-over-year. Full-year consensus is $2.1B, rising to $2.2B next year.
Top analysts covering Qiagen NV
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on QGEN.
#1
Luke Sergott
Barclays · Rank #246
Hold
$40.00-5.6% to target
Overall win rate
40%
+ Follow
#2
Patrick Donnelly
Citigroup · Rank #344
Hold
$38.00-10.4% to target
Overall win rate
30%
+ Follow
#3
JK
Jan Koch
Deutsche Bank
Buy
No targeton QGEN
Coverage
—
+ Follow
#4
CW
Casey Woodring
JP Morgan
Buy
$50.00+18.0% to target
Coverage
—
+ Follow
#5
Daniel Arias
Stifel
Hold
$40.00-5.6% to target
Coverage
—
+ Follow
QGEN stock forecast FAQ
What is QGEN's average 12-month price target?+
The 8 analysts with a live target average $43.75 for Qiagen NV over the next 12 months, ranging from a $54.00 high to a $36.00 low.
Is QGEN stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 8 analyst ratings, 4 are Buy or Strong Buy, 4 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for QGEN?+
The Street-high target is $54.00 (Deutsche Bank), and the Street-low is $36.00 (Stifel). The average of all 8 active targets is $43.75.
How many Wall Street analysts cover QGEN?+
8 analysts have an active rating on Qiagen NV, and 8 firms carry a live 12-month price target.
Who is the most accurate analyst covering QGEN?+
Among analysts who currently cover QGEN, Luke Sergott of Barclays has the strongest overall Quantellect track record (Rank #246). Their current call is Hold with a $40.00 target.
What is Qiagen NV's projected EPS for next quarter?+
The consensus estimate is $0.65 per share (range $0.64 – $0.67) across 8 analysts. Full-year EPS is projected at $2.43, rising to $2.61 the following year.
How much revenue is Qiagen NV expected to report next quarter?+
Consensus revenue is $573.7M (range $569.0M – $584.0M). Full-year revenue is projected at $2.1B, growing to $2.2B next year.
Have analysts been upgrading or downgrading QGEN lately?+
As of Sep, 4 of 8 firms rate QGEN a Buy (4 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their QGEN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
Citigroup
